secwatch.observer — SEC 8-K summary
======================================

Issuer:     Varex Imaging Corp (VREX)
CIK:        0001681622
Form:       8-K
Filed at:   2023-05-02T23:59:59+00:00
Accession:  0001681622-23-000047
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Varex Q2 FY2023 revenue $228M beats guidance; non-GAAP EPS $0.26
----------------------------------------------------------------

- Revenue $228M, up 6% YoY and 11% sequentially; GAAP EPS $0.10, non-GAAP EPS $0.26.
- Medical segment rev $174M (+2% YoY); Industrial segment rev $54M (+22% YoY).
- Cash flow from operations $27M; cash, equivalents, securities $122M, up $14M sequentially.
- Q3 FY2023 guidance: revenue $220–$240M, non-GAAP EPS $0.20–$0.40.
- Management cites strong demand, exceeded high-end of guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681622/000168162223000047/0001681622-23-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681622/000168162223000047/vrex-20230502.htm
  HTML page:      https://secwatch.observer/filing/0001681622-23-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer